[SCHEDULE 13G] U S PHYSICAL THERAPY INC /NV SEC Filing

Rhea-AI Filing Summary

U.S. Physical Therapy, Inc. (USPH) received a Schedule 13G from Copeland Capital Management, LLC disclosing beneficial ownership of 843,981 shares, representing 5.54% of the common stock as of 09/30/2025.

The filer reports sole voting power over 551,532 shares, shared voting power over 144,267 shares, sole dispositive power over 0 shares, and shared dispositive power over 843,981 shares. The reporting person is classified as an investment adviser (IA). The certification and signature were provided by Sofia A. Rosala, General Counsel and CCO.

Insights

Securities law analyst

Disclosure of 5.54% beneficial ownership; administrative update.

Copeland Capital Management, LLC filed a Schedule 13G on USPH, reporting 843,981 shares or 5.54% as of 09/30/2025. The filing lists sole voting over 551,532 shares and shared voting over 144,267, with shared dispositive power over 843,981 and no sole dispositive power.

Schedule 13G is a beneficial ownership disclosure. Actual market impact depends on holder activity; the document does not state transaction plans. The reporting person is an investment adviser, which can reflect aggregated client accounts.

Future ownership changes, if any, would appear in subsequent beneficial ownership updates. No cash-flow is described; the filing records current ownership and voting/dispositive allocations only.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

U S PHYSICAL THERAPY INC /NV

(Name of Issuer)

Common Stock

(Title of Class of Securities)

90337L108

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 90337L108

1

Names of Reporting Persons

Copeland Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 551,532.00
6	Shared Voting Power 144,267.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 843,981.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

843,981.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.54 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: U S PHYSICAL THERAPY INC /NV
(b)	Address of issuer's principal executive offices: 1300 West Sam Houston Parkway South, Suite 300, Houston TX 77042
Item 2.
(a)	Name of person filing: Sofia A. Rosala
(b)	Address or principal business office or, if none, residence: 161 Washington St, Suite 1325, Conshohocken, PA 19428
(c)	Citizenship: U.S.A.
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 90337L108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 843981
(b)	Percent of class: 5.54 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 551532
	(ii) Shared power to vote or to direct the vote: 144267
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 843981
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Rule 13d-1(b) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Copeland Capital Management, LLC

Signature:	/s/ Sofia A. Rosala
Name/Title:	Sofia A. Rosala, General Counsel and CCO
Date:	10/14/2025

FAQ

What stake in USPH did Copeland Capital report?

Copeland Capital Management reported 843,981 shares, representing 5.54% of U.S. Physical Therapy's common stock as of 09/30/2025.

How many USPH shares does Copeland Capital have sole voting power over?

The filer reports sole voting power over 551,532 shares of USPH.

What is Copeland Capital's dispositive power over USPH shares?

The filer reports sole dispositive power over 0 shares and shared dispositive power over 843,981 shares.

What type of reporting person is Copeland Capital in this filing?

The reporting person is classified as an investment adviser (IA).

When is the date of the event triggering this ownership report for USPH?

The date of the event requiring the filing is 09/30/2025.

Who signed the Schedule 13G for Copeland Capital?

The filing was signed by Sofia A. Rosala, General Counsel and CCO.